Ophthalmic Drugs Market

Ophthalmic Drugs Market Study by Anti-inflammatory Drugs, Anti-infective Drugs, Anti-glaucoma Drugs, Anti-allergy Drugs, and Anti-VEGF Drugs from 2023 to 2033

Analysis of Ophthalmic Drugs Market Covering 30+ Countries Including Analysis of US, Canada, UK, Germany, France, Nordics, GCC countries, Japan, Korea and many more

FACT4799MR
02 Feb 2023
Healthcare
170 Pages
55 Tables
90 Figures

Table of Content

1. Preface
2. Assumptions and Research Methodology
3. Executive Summary: Global Market
4. Market Overview
5. Global Market Analysis and Forecasts, By Disease Indication
- 5.1. Dry Eye
- 5.2. Glaucoma
- 5.3. Infection/Inflammation
- 5.4. Retinal Disorders
  - 5.4.1. Wet AMD
  - 5.4.2. Dry AMD
  - 5.4.3. Diabetic Retinopathy
  - 5.4.4. Others
- 5.5. Allergy
- 5.6. Uveitis
- 5.7. Others
6. Global Market Analysis and Forecasts, By Therapeutic Class
- 6.1. Anti-inflammatory Drugs
  - 6.1.1. NSAID
  - 6.1.2. Steroids
- 6.2. Anti-infective Drugs
  - 6.2.1. Anti-fungal Drugs
  - 6.2.2. Anti-bacterial Drugs
  - 6.2.3. Others
- 6.3. Anti-glaucoma Drugs
  - 6.3.1. Alpha Agonist
  - 6.3.2. Beta Blockers
  - 6.3.3. Prostaglandin Analogs
  - 6.3.4. Combined Medication
  - 6.3.5. Others
- 6.4. Anti-allergy Drugs
- 6.5. Anti-VEGF Agents
- 6.6. Others
7. Global Market Analysis and Forecasts, By Product Type
- 7.1. Prescription Drugs
- 7.2. OTC Drugs
8. Global Market Analysis and Forecasts, By Distribution Channels
- 8.1. Hospital Pharmacies
- 8.2. Online Pharmacies
- 8.3. Independent Pharmacies & Drug Stores
9. Global Market Analysis and Forecasts, By Region
- 9.1. North America
- 9.2. Europe
- 9.3. Asia Pacific
- 9.4. Latin America
- 9.5. Middle East and Africa
10. North America Market Analysis and Forecast
11. Europe Market Analysis and Forecast
12. Asia Pacific Market Analysis and Forecast
13. Latin America Market Analysis and Forecast
14. Middle East and Africa Market Analysis and Forecast
15. Competition Landscape
- 15.1. Aerie Pharmaceuticals, Inc.
- 15.2. ALLERGAN
- 15.3. Valeant Pharmaceuticals International, Inc.
- 15.4. Bayer AG
- 15.5. Genentech, Inc. (F. Hoffmann-La Roche Ltd.)
- 15.6. Novartis AG
- 15.7. Pfizer Inc.
- 15.8. Regeneron Pharmaceuticals, Inc.
- 15.9. Santen Pharmaceutical Co., Ltd.
- 15.10. Shire

List Of Table

Table 01: Product Offering - Major Market Players

Table 02: Global Market Size (US$ Mn) Forecast, by Disease Indication, 2023 to 2033

Table 03: Global Market Size (US$ Mn) Forecast, Market Forecast, by Disease Indication - Retinal Disorder, 2023 to 2033

Table 04: Global Market Size (US$ Mn) Forecast, by Therapeutic Class, 2023 to 2033

Table 05: Global Market Size (US$ Mn) Forecast, by Therapeutic Class - Anti-inflammatory Drugs, 2023 to 2033

Table 06: Global Market Size (US$ Mn) Forecast, by Therapeutic Class - Anti-infective Drugs, 2023 to 2033

Table 07: Global Market Size (US$ Mn) Forecast, by Therapeutic Class - Anti-glaucoma Drugs, 2023 to 2033

Table 08: Global Market Size (US$ Mn) Forecast, by Product Type, 2023 to 2033

Table 09: Global Market Size (US$ Mn) Forecast, by Distribution Channel, 2023 to 2033

Table 10: Global Market Size (US$ Mn) Forecast, by Region, 2023 to 2033

Table 11: North America Market Size (US$ Mn) Forecast, by Country, 2023 to 2033

Table 12: North America Market Size (US$ Mn) Forecast, by Disease Indication, 2023 to 2033

Table 13: North America Market Size (US$ Mn) Forecast, Market Forecast, by Disease Indication – Retinal Disorder, 2023 to 2033

Table 14: North America Market Size (US$ Mn) Forecast, by Therapeutic Class, 2023 to 2033

Table 15: North America Market Size (US$ Mn) Forecast, by Therapeutic Class - Anti-inflammatory Drugs, 2023 to 2033

Table 16: North America Market Size (US$ Mn) Forecast, by Therapeutic Class - Anti-infective Drugs, 2023 to 2033

Table 17: North America Market Size (US$ Mn) Forecast, by Therapeutic Class - Anti-glaucoma Drugs, 2023 to 2033

Table 18: North America Market Size (US$ Mn) Forecast, by Product Type, 2023 to 2033

Table 19: North America Market Size (US$ Mn) Forecast, by Distribution Channels, 2023 to 2033

Table 20: Europe Market Size (US$ Mn) Forecast, by Country/Sub-Region, 2023 to 2033

Table 21: Europe Market Size (US$ Mn) Forecast, by Disease Indication, 2023 to 2033

Table 22: Europe Market Size (US$ Mn) Forecast, Market Forecast, by Disease Indication – Retinal Disorder, 2023 to 2033

Table 23: Europe Market Size (US$ Mn) Forecast, by Therapeutic Class, 2023 to 2033

Table 24: Europe Market Size (US$ Mn) Forecast, by Therapeutic Class - Anti-inflammatory Drug, 2023 to 2033

Table 25: Europe Market Size (US$ Mn) Forecast, by Therapeutic Class - Anti-infective Drug, 2023 to 2033

Table 26: Europe Market Size (US$ Mn) Forecast, by Therapeutic Class - Anti-glaucoma Drug, 2023 to 2033

Table 27: Europe Market Size (US$ Mn) Forecast, by Product Type, 2023 to 2033

Table 28: Europe Market Size (US$ Mn) Forecast, by Distribution Channel, 2023 to 2033

Table 29: Asia Pacific Market Size (US$ Mn) Forecast, by Country/Sub-region, 2023 to 2033

Table 30: Asia Pacific Market Size (US$ Mn) Forecast, by Disease Indication, 2023 to 2033

Table 31: Asia Pacific Market Size (US$ Mn) Forecast, by Disease Indication – Retinal Disorder, 2023 to 2033

Table 32: Asia Pacific Market Size (US$ Mn) Forecast, by Therapeutic Class, 2023 to 2033

Table 33: Asia Pacific Market Size (US$ Mn) Forecast, by Therapeutic Class – Anti-inflammatory Drugs, 2023 to 2033

Table 34: Asia Pacific Market Size (US$ Mn) Forecast, by Therapeutic Class – Anti-infective Drugs, 2023 to 2033

Table 35: Asia Pacific Market Size (US$ Mn) Forecast, by Therapeutic Class – Anti-glaucoma Drugs, 2023 to 2033

Table 36: Asia Pacific Market Size (US$ Mn) Forecast, by Product Type, 2023 to 2033

Table 37: Asia Pacific Market Size (US$ Mn) Forecast, by Distribution Channel, 2023 to 2033

Table 38: Latin America Market Size (US$ Mn) Forecast, by Country/Sub-region, 2023 to 2033

Table 39: Latin America Market Size (US$ Mn) Forecast, by Disease Indication, 2023 to 2033

Table 40: Latin America Market Size (US$ Mn) Forecast, by Disease Indication – Retinal Disorder, 2023 to 2033

Table 41: Latin America Market Size (US$ Mn) Forecast, by Therapeutic Class, 2023 to 2033

Table 42: Latin America Market Size (US$ Mn) Forecast, by Therapeutic Class – Anti-inflammatory Drugs, 2023 to 2033

Table 43: Latin America Market Size (US$ Mn) Forecast, by Therapeutic Class – Anti-infective Drugs, 2023 to 2033

Table 44: Latin America Market Size (US$ Mn) Forecast, by Therapeutic Class – Anti-glaucoma Drugs, 2023 to 2033

Table 45: Latin America Market Size (US$ Mn) Forecast, by Product Type, 2023 to 2033

Table 46: Latin America Market Size (US$ Mn) Forecast, by Distribution Channel, 2023 to 2033

Table 47: Middle East & Africa Market Size (US$ Mn) Forecast, by Country/Sub-Region, 2023 to 2033

Table 48: Middle East & Africa Market Size (US$ Mn) Forecast, by Disease Indication, 2023 to 2033

Table 49: Middle East & Africa Market Size (US$ Mn) Forecast, by Disease Indication - Retinal Disorder, 2023 to 2033

Table 50: Middle East & Africa Market Size (US$ Mn) Forecast, by Therapeutic Class, 2023 to 2033

Table 51: Middle East & Africa Market Size (US$ Mn) Forecast, by Therapeutic Class - Anti-inflammatory Drugs, 2023 to 2033

Table 52: Middle East & Africa Market Size (US$ Mn) Forecast, by Therapeutic Class - Anti-infective Drugs, 2023 to 2033

Table 53: Middle East & Africa Market Size (US$ Mn) Forecast, by Therapeutic Class - Anti-glaucoma Drugs, 2023 to 2033

Table 54: Middle East & Africa Market Size (US$ Mn) Forecast, by Product Type, 2023 to 2033

Table 55: Middle East & Africa Market Size (US$ Mn) Forecast, by Distribution Channel, 2023 to 2033

List Of Figures

Figure 01: Global Market Size (US$ Mn) Forecast, 2023 to 2033

Figure 02: Global Company Share: Anti-glaucoma Drugs, 2018

Figure 03: Global Causes of Blindness

Figure 04: U.S. - Causes of Blindness

Figure 05: Europe - Causes of Blindness

Figure 06: Japan Causes of Blindness

Figure 07: Global Market Attractiveness, by Disease Indication, 2023 to 2033

Figure 08: Global Market Value Share, by Disease Indication, 2023 and 2033

Figure 09: Global Market Revenue (US$ Mn) and Y-o-Y Growth Projection (%), by Dry Eye, 2023 to 2033

Figure 10: Global Market Revenue (US$ Mn) and Y-o-Y Growth Projection (%), by Glaucoma, 2023 to 2033

Figure 11: Global Market Revenue (US$ Mn) and Y-o-Y Growth Projection (%), by Infection/Inflammation, 2023 to 2033

Figure 12: Global Market Revenue (US$ Mn) and Y-o-Y Growth Projection (%), by Retinal Disorders, 2023 to 2033

Figure 13: Global Market Revenue (US$ Mn) and Y-o-Y Growth Projection (%), by Uveitis, 2023 to 2033

Figure 14: Global Market Revenue (US$ Mn) and Y-o-Y Growth Projection (%), by Allergy, 2023 to 2033

Figure 15: Global Market Revenue (US$ Mn) and Y-o-Y Growth Projection (%), by Other Ophthalmic Diseases, 2023 to 2033

Figure 16: Global Market Attractiveness, by Therapeutic Class, 2023 to 2033

Figure 17: Global Market Value Share, by Therapeutic Class, 2023 and 2033

Figure 19: Global Market, by Anti-infective Drugs, Revenue (US$ Mn) and Y-o-Y Growth Projection (%), 2023 to 2033

Figure 18: Global Market, by Anti-inflammatory Drugs Revenue (US$ Mn) and Y-o-Y Growth Projection (%), 2023 to 2033

Figure 20: Global Market, by Anti-glaucoma Drugs, Revenue (US$ Mn) and Y-o-Y Growth Projection (%), 2023 to 2033

Figure 21: Global Market, by Anti-VEGF Agents, Revenue (US$ Mn) and Y-o-Y Growth Projection (%), 2023 to 2033

Figure 22: Global Market, by Anti-allergy Drugs, Revenue (US$ Mn) and Y-o-Y Growth Projection (%), 2023 to 2033

Figure 23: Global Market, by Others Drugs, Revenue (US$ Mn) and Y-o-Y Growth Projection (%), 2023 to 2033

Figure 24: Global Market Value Share, by Product Type, for 2023 and 2033

Figure 25: Global Market Attractiveness, by Product Type, 2023 to 2033

Figure 26: Global Market Revenue (US$ Mn) and Y-o-Y Growth Projection (%), by Prescription Drugs, 2023 to 2033

Figure 27: Global Market Revenue (US$ Mn) and Y-o-Y Growth Projection (%), by OTC Drugs, 2023 to 2033

Figure 28: Global Market Value Share, by Distribution Channel, for 2023 and 2033

Figure 29: Global Market Attractiveness, by Distribution Channel, 2023 to 2033

Figure 30: Global Market Revenue (US$ Mn) and Y-o-Y Growth Projection (%), by Online Pharmacies, 2023 to 2033

Figure 31: Global Market Revenue (US$ Mn) and Y-o-Y Growth Projection (%), by Hospital Pharmacies, 2023 to 2033

Figure 32: Global Market Revenue (US$ Mn) and Y-o-Y Growth Projection (%), by Independent Pharmacies & Drug Stores, 2023 to 2033

Figure 33: Global Market Value Share, by Region, for 2023 and 2033

Figure 34: Global Market Attractiveness, by Region, 2023 to 2033

Figure 35: North America Market Size (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2023 to 2033

Figure 36: North America Market Attractiveness, by Country, 2023 to 2033

Figure 37: North America Market Value Share, by Country, 2023 and 2033

Figure 38: North America Market Attractiveness, By Disease Indication, 2023 to 2033

Figure 39: North America Market Value Share, by Disease Indication, 2023 and 2033

Figure 40: North America Market Value Share, by Therapeutic Class, 2023 and 2033

Figure 41: North America Market Attractiveness, by Therapeutic Class, 2023 to 2033

Figure 42: North America Market Value Share Analysis, by Product Type, 2023 and 2033

Figure 43: North America Market Attractiveness, by Product Type, 2023 to 2033

Figure 44: North America Market Value Share, by Distribution Channels, 2023 and 2033

Figure 45: North America Market Attractiveness, by Distribution Channels, 2023 to 2033

Figure 46: Europe Market Size (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2023 to 2033

Figure 47: Europe Market Attractiveness, by Country/Sub-Region, 2023 to 2033

Figure 48: Europe Market Value Share, by Country/Sub-Region, 2023 and 2033

Figure 49: Europe Market Attractiveness, By Disease Indication, 2015-2025

Figure 50: Europe Market Value Share, by Disease Indication, 2023 and 2033

Figure 51: Europe Market Value Share, by Therapeutic Class, 2023 and 2033

Figure 52: Europe Market Attractiveness, by Therapeutic Class, 2023 to 2033

Figure 53: Europe Market Value Share Analysis, by Product Type, 2023 and 2033

Figure 54: Europe Market Attractiveness, by Product Type, 2023 to 2033

Figure 55: Europe Market Value Share, by Distribution Channel, 2023 and 2033

Figure 56: Europe Market Attractiveness, by Distribution Channel, 2023 to 2033

Figure 57: Asia Pacific Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2023 to 2033

Figure 58: Asia Pacific Market Attractiveness, by Country/Sub-region, 2023 to 2033

Figure 59: Asia Pacific Market Value Share, by Country/Sub-region, for 2023 and 2033

Figure 60: Asia Pacific Market Attractiveness, by Disease Indication, 2023 to 2033

Figure 61: Asia Pacific Market Value Share, by Disease Indication, for 2023 and 2033

Figure 62: Asia Pacific Market Attractiveness, by Therapeutic Class, 2023 to 2033

Figure 63: Asia Pacific Market Value Share, by Therapeutic Class, for 2023 and 2033

Figure 64: Asia Pacific Market Value Share Analysis, by Product Type, for 2023 and 2033

Figure 65: Asia Pacific Market Attractiveness, by Product Type, 2023 to 2033

Figure 66: Asia Pacific Market Value Share, by Distribution Channel, for 2023 and 2033

Figure 67: Asia Pacific Market Attractiveness, by Distribution Channel, 2023 to 2033

Figure 68: Latin America Market Size (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2023 to 2033

Figure 69: Latin America Market Attractiveness, by Country/Sub-region, 2023 to 2033

Figure 70: Latin America Market Value Share, by Country/Sub-region, 2023 and 2033

Figure 71: Latin America Market Attractiveness, by Disease Indication, 2023 to 2033

Figure 72: Latin America Market Value Share, by Disease Indication, 2023 and 2033

Figure 73: Latin America Market Attractiveness, by Therapeutic Class, 2023 to 2033

Figure 74: Latin America Market Value Share, by Therapeutic Class, 2023 and 2033

Figure 75: Latin America Market Value Share Analysis, by Product Type, 2023 and 2033

Figure 76: Latin America Market Attractiveness, by Product Type, 2023 to 2033

Figure 77: Latin America Market Value Share, by Distribution Channel, 2023 and 2033

Figure 78: Latin America Market Attractiveness, by Distribution Channel, 2023 to 2033

Figure 79: Middle East & Africa Market Size (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2023 to 2033

Figure 80: Middle East & Africa Market Attractiveness, by Country/Sub-Region, 2023 to 2033

Figure 81: Middle East & Africa Market Value Share, by Country/Sub-Region, 2023 and 2033

Figure 82: Middle East & Africa Market Attractiveness, by Disease Indication, 2023 to 2033

Figure 83: Middle East & Africa Market Value Share, by Disease Indication, 2023 and 2033

Figure 84: Middle East & Africa Market Attractiveness, by Therapeutic Class, 2023 to 2033

Figure 85: Middle East & Africa Market Value Share, by Therapeutic Class, 2023 and 2033

Figure 86: Middle East & Africa Market Value Share Analysis, by Product Type, 2023 and 2033

Figure 87: Middle East & Africa Market Attractiveness, by Product Type, 2023 to 2033

Figure 88: Middle East & Africa Market Value Share, by Distribution Channel, 2023 and 2033

Figure 89: Middle East & Africa Market Attractiveness, by Distribution Channel, 2023 to 2033

Figure 90: Global Market Share, by Company, 2018

Ophthalmic Drugs Market

Free Sample Buy Report Now